Brian Wolpin, MD, MPH, Director of the Hale Family Center for Pancreatic Cancer Research at Dana-Farber will report at ASCO26 that daraxonrasib showed significant improvements in overall survival and ...
Workflow for prediction of 177 Lu-PSMA therapy absorbed dose using pre-therapy 18 F-PSMA PET/CT. Courtesy of SNMMI.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results